Skip to main content
Department of Medicine

Research section navigation

Basic scientists, clinical researchers, and clinicians in the Department of Medicine work side-by-side to address fundamental problems in human disease. Their collaborative efforts enable them to take mechanistic discoveries to preclinical testing and first-in-man clinical trials. Cross-cutting programs include regenerative medicine, vaccine testing and development, immunology and inflammation, outcomes and health services research, and the molecular basis of disease.

Support for Researchers

The Department of Medicine offers services and resources for investigators, including funding opportunities, training programs, and more.

We also offer event programming designed specifically for investigators at all stages of their research careers.

Explore Research by Division

The Department of Medicine's ten divisions have funded investigators who study clinically relevant questions from all perspectives.

Research Centers and Institutes

We operate world-renowned research centers for basic, translational, and clinical research related to physiology, therapeutics, and diseases pathogenesis.

Clinical Trials

We are proud to offer a large number of clinical trials for patients and potential patients.

Contact Us

View a list of relevant contacts for the Department of Medicine's Office of Research.

The National Institute of Allergy and Infectious Diseases (NIAID) has selected Emory University to lead a new effort aimed at developing vaccines and other therapies to combat infectious diseases.

David S. Stephens, MD, professor and chair of the Department of Medicine will serve as the ID leadership group’s principal investigator along with Kathleen Neuzil, MD, professor of medicine and pediatrics at the University of Maryland, Baltimore.

FY20 Research by the Numbers

$151.7 million in research funding (FY20)

1,070 faculty publications

21 active NIH K awards and 52 active RO1s

497 active clinical trials with 8,121 enrollees

Featured Research Zebrafish: Mini Monsters of Cardiac Regeneration

After a heart attack, cardiac muscle cells die because they are deprived of blood and oxygen. In an adult human, those cells represent a dead end. They can’t change their minds about what kind of cell they’ve become.

In newborn babies, as well as in adult fish, the heart can regenerate after injury. Why can’t the human heart be more fishy? At Emory, researcher Jinhu Wang is seeking answers, which could guide the development of regenerative therapies.

Research Events

Loading Events...